Ubs Group Ag Scholar Rock Holding Corp Call Options Transaction History
Ubs Group Ag
- $400 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SRRK
# of Institutions
174Shares Held
75.4MCall Options Held
151KPut Options Held
40.1K-
Artal Group S.A. Luxembourg, N411.3MShares$343 Million5.94% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.19MShares$249 Million0.01% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA6.79MShares$207 Million29.08% of portfolio
-
Black Rock Inc. New York, NY5.66MShares$172 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA5.45MShares$166 Million2.96% of portfolio
About Scholar Rock Holding Corp
- Ticker SRRK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,640,600
- Market Cap $1.57B
- Description
- Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...